Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Kerrie brings you Sunday's pollen forecast
Kerrie brings you Sunday's forecast
Prime Minister describes her visit to Manchester Children's Hospital to meet victims, many of whom are from the North East